Condensed Balance Sheets - USD ($)	Mar. 31, 2025	Dec. 31, 2024
Cash	$ 57	$ 526
Other current assets	3,399	7,894
Notes receivable – current portion	383,777	371,170
Total Current Assets	387,233	379,590
Plant and equipment	4,316	4,858
Equity method investment	1	1
Total Non-Current Assets	4,317	4,859
Total Assets	391,550	384,449
Bank overdraft	151
Accounts payable	2,989,714	2,986,039
Federal relief loans – current portion	10,036	8,869
Notes payable, net of unamortized discount of $42,867 and $89,062, respectively	1,769,646	1,669,873
Convertible debt, net of unamortized discount of $61,845 and $80,971, respectively	5,224,357	5,016,205
Derivative liability	4,169,250	1,138,204
Total Current Liabilities	14,168,260	10,819,190
Federal relief loans	150,000	150,000
Total Non-Current Liabilities	150,000	150,000
Total Liabilities	14,318,260	10,969,190
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of March 31, 2025 and December 31, 2024.
Common stock, $0.0001 par value; 750,000,000 shares authorized. 73,889,435 and 19,081,446 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively.	7,389	1,908
Additional paid-in-capital	52,954,852	52,202,117
Accumulated deficit	(66,888,951)	(62,788,766)
Total Stockholders’ (deficit)	(13,926,710)	(10,584,741)
Total Liabilities and Stockholders’ (Deficit)	391,550	384,449
Related Party
Related party payables	$ 5,106